UTUC |
Upper-tract urothelial carcinoma |
M-VAC |
Methotrexate, Vinblastine, Doxorubicin, and Cisplatin |
eGFR |
Estimated glomerular filtration rate |
CTLA-4 |
Cytotoxic T lymphocyte antigen 4 |
LDHA |
Lactate dehydrogenase A |
GLUT |
Glucose transporters |
GLUL |
Glutamine synthetase |
PD-L1 |
Programmed death ligand 1 |
UCB |
Urothelial carcinoma of the bladder |
APC |
Antigen-presenting cell |
PD-1 |
Programmed death 1 |
FDA |
Food and Drug Administration |
TME |
Tumor microenvironment |
UC |
Urothelial carcinoma |
AA |
Aristolochic acid |
ICI |
Immune checkpoint inhibitor |
GC |
Gemcitabine plus cisplatin |
NO |
Nitrous oxide |